☆ 4.6 Article

Economic Evaluation of Pertuzumab In Combination with Trastuzumab and Docetaxel in the Neoadjuvant Treatment of Women with HER2-Positive, Locally Advanced, Inflammatory or Early Breast Cancer in Portugal

VALUE IN HEALTH (2016)

Get Full Text
Add to Collection

Journal

VALUE IN HEALTH
Volume 19, Issue 7, Pages A736-A737

Publisher

Elsevier BV
DOI: 10.1016/j.jval.2016.09.2231

Keywords

-

Categories

Economics

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.